We Accelerate Discovery

You are here


Program Snapshot

Complex multicellular organs and organisms are dependent upon the roles of carbohydrates for assembly. The use of glycans as biological targets for drug discovery has been hindered by the inability to easily synthesize, sequence and study their biological functions. The complexity of carbohydrate chemistry makes glycoscience inaccessible to most biomedical researchers. The NIH Common Fund Glycoscience Program is focused on creating new methodologies and resources to study glycans, and to develop these resources so they may be more easily understood and accessed by the broader biomedical research community.

Read more…

Program Highlight

Launch of the Common Fund Glycoscience Program

Read the press release announcing the Glycoscience program and other new Common Fund programs!

During the 2013-2014 Common Fund strategic planning process, the NIH community identified the need to develop accessible new tools and technologies that will make the study of glycans possible for any biomedical investigator. Glycans participate in multiple fundamental cellular mechanisms that contribute to health and disease, yet they are difficult for many researchers to study. The newly-launched Glycoscience Program will design initiatives to encourage new strategies and high-risk approaches for methods and tool development with the ultimate goal of rapid transition of successful projects to commercialization.



Up to Top